Skip to content
Texas Instruments (TXN) sees third-quarter sales beating analysts’ expectations as the work-from-home environment continues to drive demand for the chipmaker’s products for personal computers, tablets and servers.Texas Instruments projects current-quarter revenue will be in a range of $3.26 billion to $3.54 billion, which is above analysts’ expectations of $3.12 billion. Earnings are expected to be in the range of $1.14 to $1.34 a share compared with the 98 cents forecast by an average of analysts.“We will maintain high optionality so we can continue to support customers' demand, particularly during a time when their ability to forecast may continue to be limited,” said Texas Instruments CFO Rafael R. Lizardi. “We have informed our customers that lead times on our products remain short, and more than 40,000 products are available for immediate shipment on TI.com.”In the quarter ended June 30, the chipmaker saw net income increasing to $1.38 billion, or $1.48 per share, from...
Intuitive Surgical (ISRG) has delivered another strong quarter driven by better-than-expected system placements and procedure volume. Shares in the robotic surgery company rose 2% in Tuesday’s after-hours trading, with the stock now up 11% year-to-date.Second quarter Non-GAAP EPS of $1.11 beat Street estimates by $0.62 while revenue of $852.1M beat forecasts by $215.26M, despite falling 22% year-over-year. Also encouraging was the number of the company’s daVinci systems shipped at 178 (down 3.5% year-over-year), versus the Street’s estimated 141. Procedure volume declined by 19% year-over-year, but was nevertheless an improvement on the consensus estimate of 29%.However, GAAP EPS of $0.57 missed Street expectations by $0.14.During the first six months of 2020, the company stated that it experienced a significant decline in procedure volume and postponements of system placements, as healthcare systems around the world diverted resources to meet the increasing demands of managing COVID-19.The impact and timing of the COVID-19 pandemic on the ISRG differed...
Salesforce (CRM) has quietly shut down Einstein Voice Assistant and Einstein Voice Skills, less than two years after launch. “Einstein Voice will usher in a new era of conversational CRM, delivering new levels of productivity and redefining customer experiences with voice technology,” Salesforce CTO Parker Harris told the Dreamforce conference audience back in 2018.Now however the focus has shifted to Salesforces’ other voice enterprises. “Voice is a priority for us at Salesforce, and voice capabilities are built into various product and Platform services,” a Salesforce spokesperson told Voicebot in an email. “For example, Service Cloud Voice and Einstein Call Coaching are both based on voice technology, and the new Salesforce Anywhere app will also contain voice capabilities.”The spokesperson continued: “Our learnings will continue to inform our new product, the Salesforce Anywhere App. The app will include voice functionality in a new reimagined way to increase remote productivity, ease of use and...
Medical tech giant Boston Scientific Corporation (BSX) has announced that it has received U.S. Food and Drug Administration (FDA) approval for its next-generation heart device, the Watchman FLX Left Atrial Appendage Closure (LAAC) Device.The device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage – the area of the heart where stroke-causing blood clots commonly form.According to the company, it is the first LAAC device that can be fully recaptured, repositioned and redeployed for precise placement, with better long-term stability and a faster, more complete seal. It can also treat a wider range of patient anatomies.“Our WATCHMAN technology was the first FDA-approved LAAC device on the market and has been implanted in more than 100,000 patients worldwide, and now with the WATCHMAN FLX device, we are taking the clinical benefits of...
Shares in Snap Inc. (SNAP) dropped over 6% in extended market trading after its second-quarter loss widened and user growth figures disappointed.The stock declined to $23.17 in Tuesday’s after-market trading. Snap reported a net loss of $326 million, or 23 cents per share, in the quarter ended June, widening from $255.2 million, or 19 cents per share, in the year-earlier period. Meanwhile, total revenue increased 17% to $454 million during the reported period.Daily active users (DAUs), a widely followed metric by investors and advertisers, increased 17% to 238 million in the second quarter year-on-year but fell short of analysts’ expectations of 238.44 million. For the current quarter, Snap expects 242 million to 244 million daily active users, below analysts’ estimates of 244.82 million.“We continued to grow our community and business in a challenging and uncertain environment,” said Snap CEO Evan Spiegel. “We are grateful that the resilience of our business has...
